News
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...
A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute ...
DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...
The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for individuals ... 4 in-clinic sessions for blood draws; glucose concentrations ...
Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.
(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...
a blood glucose monitoring device with the tools and a support system to put in control of the diabetes and not the other way around. Checking the blood glucose with the BGStarTM couldn’t be ...
AWS is collaborating with the Vivalink Biometrics Data Platform (VBDP), an advanced system for continuous remote patient ...
Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...
The iBGStarTM not only gives accurate blood glucose readings, but when linked to the iPhone or iPod Touch, it provides a wealth of information. Checking the blood glucose readings with the ...
Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results